Novo Nordisk partners with Foment del Treball Nacional to strengthen its presence in Catalonia
Novo Nordisk se alía con Foment del Treball Nacional para potenciar su presencia en Cataluña
Intel ID : 384613
Bidder
|
||||
Ultimate Owner (Buyer)
|
| Intel ID | 384613 | |||
| Value | ND | |||
| Native Currency | Euro (EUR) | |||
|
Financial Data - Novo Nordisk Pharma
(31 Dec 2023) |
Revenue: EUR 499,43m EBITDA: EUR 17,75m Net Debt: EUR 65,83m People: 381 |
|||
| Date |
 |
|||
| Country | |
|||
| Geography |  |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 50.02.01 Business & Professional NGOs (Primary) 50 Public Services & NGOs / 50.02 Non-Governmental Institutions, Organizations & Associations |
|||
| Type |
|
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
50.02.01 Business & Professional NGOs 50 Public Services & NGOs / 50.02 Non-Governmental Institutions, Organizations & Associations |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.05.05 Drug Stores & Pharmacies 15 Consumer Products & Services / 15.05 Distribution & Retail |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.